How much is Sydnexis worth in 2026?

Sydnexis has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Sydnexis raised?

Sydnexis has raised $76.5M in total funding across 1 funding rounds.

Sydnexis

Drug DiscoveryWebsite

Sydnexis valuation and funding history | Last updated: April 15, 2025 | 1 funding rounds

Current Valuation

N/A

As of April 15, 2025

Total Funding Raised

$76.5M

Across 1 round

Last Round

Later Stage VC

$20.0M

Last Funding

Apr 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 10, 2021	Later Stage VC (Series B)	$50.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Sydnexis is currently valued at N/A as of April 15, 2025. The company has raised a total of $76.5M in funding across 1 funding round.

Track Sydnexis Valuation Updates

Get notified when Sydnexis raises new funding or valuation changes

Explore More Data

Detailed analysis for Sydnexis

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Sydnexis's valuation history, funding rounds, and growth metrics.

No credit card required

What is Sydnexis Worth in 2026?

Sydnexis is a leading private company in the Drug Discovery sector. Track Sydnexis's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Sydnexis Valuation is Determined

Private company valuations like Sydnexis's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.